C71T
CANCELLED SECTION 71
04/24/2026
Back to search
Official data from USPTO
RANITOPHTAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
05/19/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/05/2018
Registration date
10/08/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/24/2026
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
YOO, JEANE
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Klinge Biopharma GmbH
Klinge Pharma GmbH
Representatives
Charles T. J. Weigell FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of angiogenesis and ocular diseases and disorders
Publications
History of USPTO decisions and trademark events.
36 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/08/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/26/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/01/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/04/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/21/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/01/2020
FIMP
FINAL DISPOSITION PROCESSED
02/01/2020
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
01/08/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/10/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/08/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/15/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/02/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/23/2019
PUBO
PUBLISHED FOR OPPOSITION
07/23/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/17/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/17/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/17/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/14/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/14/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/14/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/12/2019
RFNT
REFUSAL PROCESSED BY IB
02/22/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/05/2019
RFRR
REFUSAL PROCESSED BY MPU
02/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/24/2019
CNRT
NON-FINAL ACTION WRITTEN
01/23/2019
DOCK
ASSIGNED TO EXAMINER
01/16/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/13/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/07/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/01/2018
Continuous trademark protection
Get notified about every new filing that threatens RANITOPHTAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.